ArticleInvestigative ophthalmology & visual science2026
Characterization of the Functional Transient Receptor Potential Vanilloid Channels 1 to 4 in Human Corneal Endothelial Cells.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Calcium (Ca2+) is involved in regulating many cellular functions, including the intercellular barrier integrity. This study investigated the expression, localization, and permeability of TRP-Vanilloid (TRPV1-4) channels to Ca2+ in human corneal endothelial (hCE) cells. Methods: Gene and protein level expression of the TRPV1 to 4 channels was determined by PCR, immunostaining, and Western blot analysis in hCEs from fresh human donor tissues and cultured primary cells. Colocalization of the channels with actin and junction proteins zonula occludens-1 (ZO-1) and N-cadherin was quantified by calculating Pearson's coefficient using ImageJ software. Changes to Ca2+ influx in response to channel-specific agonist and antagonist treatment were measured using Fluo-4 AM dye. Results: TRPV1 to 4 expression was confirmed in cells by PCR and Western blot. Staining revealed distinct membrane and cytoplasmic localization of these four channels. All four channels showed high colocalization with N-cadherin (r ≥ 0.7), whereas TRPV4 colocalized with N-cadherin and ZO-1 equally (r ≥ 0.8). An increase in Ca2+ influx was noted in >80% of the cells when TRPV1, TRPV2, and TRPV4 channels were activated using channel-specific agonists. A similar response was evident in only 50% of cells following TRPV3 channel activation. Pretreatment of cells with antagonists reduced agonist-induced Ca2+ influx, as noted by a significant reduction in the area under the curve of the influx profile, relative to agonist treatment. Conclusions: This study confirms TRPV1 to 4 expression, enumerates their distinct localization and colocalization with junction proteins, and their permeability to Ca2+ in hCEs. Taken together, these results suggest a potential role for these channels in maintaining Ca2+ homeostasis and barrier function in these cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.